Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excessive hair growth have a hormonal cause.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

PCOS is a complex condition linked to hormonal imbalance and insulin resistance, with weight loss being important for management.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Hair follicle size is mainly influenced by the number of cells and extracellular matrix volume, with cell number having a larger impact.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document suggests that Alopecia X in dogs is mainly a cosmetic issue and might be better left untreated.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.